Prax­is prices $150M pub­lic stock of­fer­ing ahead of four topline neu­ro read­outs in 2024

Boston-based Prax­is Pre­ci­sion Med­i­cines an­nounced Thurs­day the pric­ing of a $150 mil­lion pub­lic stock of­fer­ing, with an ex­pect­ed close date around Jan. 16.

Prax­is is sell­ing 3.16 mil­lion shares of its com­mon stock at $35.50 per share as well as pre-fund­ed war­rants to pur­chase up to an ag­gre­gate of 1.05 mil­lion shares of com­mon stock at $35.49. The un­der­writ­ers have 30 days to pur­chase up to 633,750 more shares of com­mon stock at the pub­lic of­fer­ing price.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER